Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × disitamab vedotin × Clear all

NCT06233864 2024-04-17

A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms